These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21221074)

  • 41. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
    Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice.
    Huang DD; Huang HF; Yang Q; Chen XQ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heart Rate Reduction with Ivabradine Prevents Cardiac Rupture after Myocardial Infarction in Mice.
    Ikeda M; Ide T; Furusawa S; Ishimaru K; Tadokoro T; Miyamoto HD; Ikeda S; Okabe K; Ishikita A; Abe K; Matsushima S; Tsutsui H
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):257-262. PubMed ID: 33411111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
    Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.
    Wang C; Kemp-Harper BK; Kocan M; Ang SY; Hewitson TD; Samuel CS
    Front Pharmacol; 2016; 7():91. PubMed ID: 27065874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling.
    Formigli L; Perna AM; Meacci E; Cinci L; Margheri M; Nistri S; Tani A; Silvertown J; Orlandini G; Porciani C; Zecchi-Orlandini S; Medin J; Bani D
    J Cell Mol Med; 2007; 11(5):1087-100. PubMed ID: 17979884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
    Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Schloss MJ; Horckmans M; Guillamat-Prats R; Hering D; Lauer E; Lenglet S; Weber C; Thomas A; Steffens S
    Cardiovasc Res; 2019 Mar; 115(3):602-613. PubMed ID: 30295758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.
    Li L; Okada H; Takemura G; Kosai K; Kanamori H; Esaki M; Takahashi T; Goto K; Tsujimoto A; Maruyama R; Kawamura I; Kawaguchi T; Takeyama T; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1504-13. PubMed ID: 19684189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.
    Ahmad F; Lal H; Zhou J; Vagnozzi RJ; Yu JE; Shang X; Woodgett JR; Gao E; Force T
    J Am Coll Cardiol; 2014 Aug; 64(7):696-706. PubMed ID: 25125302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
    Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
    Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function.
    Alibhai FJ; Tsimakouridze EV; Chinnappareddy N; Wright DC; Billia F; O'Sullivan ML; Pyle WG; Sole MJ; Martino TA
    Circ Res; 2014 May; 114(11):1713-22. PubMed ID: 24687134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.
    Glass C; Singla DK
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2038-49. PubMed ID: 21856911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats.
    Lee YS; Choi JW; Oh JE; Yun CO; Kim SW
    Biomaterials; 2016 Aug; 97():164-75. PubMed ID: 27174688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors.
    Tapia Cáceres F; Gaspari TA; Hossain MA; Samuel CS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice.
    Jia D; Jiang H; Weng X; Wu J; Bai P; Yang W; Wang Z; Hu K; Sun A; Ge J
    Circ Res; 2019 Apr; 124(9):1323-1336. PubMed ID: 30832557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.
    Yeh CC; Li H; Malhotra D; Turcato S; Nicholas S; Tu R; Zhu BQ; Cha J; Swigart PM; Myagmar BE; Baker AJ; Simpson PC; Mann MJ
    J Cell Biochem; 2010 Apr; 109(6):1185-91. PubMed ID: 20186881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D; Omura T; Shimada K; Matsumoto R; Kusuyama T; Enomoto S; Iwao H; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 May; 101(1):31-9. PubMed ID: 16717399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.